Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

JMML genomics and decisions

30 Nov 2018

Abstract excerpt

Abstract Juvenile myelomonocytic leukemia (JMML) is a unique clonal hematopoietic disorder of early childhood characterized by hyperactivation of the RAS signal transduction pathway. Approximately 90% of patients harbor molecular alteration in 1 of 5 genes (PTPN11, NRAS, KRAS, NF1, CBL), which define genetically and clinically distinct JMML subtypes. Three subtypes, PTPN11- , NRAS-, and KRAS-mutated JMML, are...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Protein Tyrosine Phosphatases
Share to Ubiquitin and proteasome pathways
Share to Acute Myeloid Leukemia Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30504325
DOI: 10.1182/asheducation-2018.1.307

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

JMML genomics and decisionsPMID 30504325Read ↗

Juvenile myelomonocytic leukemia: who’s the driver at the wheel?Semantic proximity Read ↗

The genomic landscape of juvenile myelomonocytic leukemia.Semantic proximity Read ↗

RAS-pathway mutation patterns define epigenetic subclasses in juvenile myelomonocytic leukemia.Semantic proximity Read ↗

Clinical and molecular characterization of patients with juvenile myelomonocytic leukaemia.Semantic proximity Read ↗

Bedside to bench in juvenile myelomonocytic leukemia: insights into leukemogenesis from a rare pediatric leukemia.Semantic proximity Read ↗

Juvenile myelomonocytic leukemia displays mutations in components of the RAS pathway and the PRC2 network.Semantic proximity Read ↗

Childhood Myelodysplastic Syndrome: Focus on the Approach to Diagnosis and Treatment of Juvenile Myelomonocytic LeukemiaSemantic proximity Read ↗

Novel approaches to diagnosis and treatment of Juvenile Myelomonocytic Leukemia.Semantic proximity Read ↗

A child with juvenile myelomonocytic leukemia possessing a concurrent germline CBL mutation and a NF1 variant of uncertain significance: A rare case with a common problem in the era of high-throughput sequencing.Semantic proximity Read ↗

Juvenile myelomonocytic leukemia - A bona fide RASopathy syndrome.Semantic proximity Read ↗

Juvenile myelomonocytic leukemia in the molecular era: a clinician's guide to diagnosis, risk stratification, and treatment.Semantic proximity Read ↗

Despite mutation acquisition in hematopoietic stem cells, JMML-propagating cells are not always restricted to this compartment.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.